Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Burn

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Scientific Reports|May 15, 2026
Venous and arterial thromboembolic events after COVID-19 during the Omicron period in three European countriesXintong Li, Annika M Jödicke, Albert Prats-Uribe, et al.
BMJ Open Respiratory Research|February 27, 2024
Real-world treatment trajectories of adults with newly diagnosed asthma or COPDAniek F Markus, Peter R Rijnbeek, Jan A Kors, et al.
Journal of the American Medical Informatics Association : JAMIA|October 20, 2022
Integrating real-world data from Brazil and Pakistan into the OMOP common data model and standardized health analytics framework to characterize COVID-19 in the Global SouthElzo Pereira Pinto Junior, Priscilla Normando, Renzo Flores-Ortiz, et al.
Frontiers in Pharmacology|September 3, 2025
Trends in prescription opioid use in Europe: A DARWIN EU<sup>®</sup> multinational cohort study including seven European countriesJunqing Xie, Mike Du, Yuchen Guo, et al.
Pharmacoepidemiology and Drug Safety|May 22, 2024
Calculating daily dose in the Observational Medical Outcomes Partnership Common Data ModelTheresa Burkard, Kim López-Güell, Artem Gorbachev, et al.
Pharmacoepidemiology and Drug Safety|October 16, 2024
Time Series Methods to Assess the Impact of Regulatory Action: A Study of UK Primary Care and Hospital Data on the Use of FluoroquinolonesYuchen Guo, Berta Raventós, Martí Català, et al.
The Lancet. Rheumatology|January 17, 2024
Opioid use, postoperative complications, and implant survival after unicompartmental versus total knee replacement: a population-based network studyEdward Burn, James Weaver, Daniel Morales, et al.
European Journal of Epidemiology|April 3, 2026
CohortCharacteristics: an R package for population characterisation in observational studies using the OMOP common data modelMike Du, Albert Prats-Uribe, Núria Mercadé-Besora, et al.
Seminars in Arthritis and Rheumatism|June 21, 2022
Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: A multinational real-world cohort analysisCynthia Yang, Ross D Williams, Joel N Swerdel, et al.
Arthritis Care & Research|March 25, 2024
Incident Use of Hydroxychloroquine for the Treatment of Rheumatoid Arthritis and Systemic Lupus Erythematosus During the COVID-19 PandemicNúria Mercadé-Besora, Yuchen Guo, Mike Du, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Scientific Reports|May 15, 2026
Venous and arterial thromboembolic events after COVID-19 during the Omicron period in three European countriesXintong Li, Annika M Jödicke, Albert Prats-Uribe, et al.
BMJ Open Respiratory Research|February 27, 2024
Real-world treatment trajectories of adults with newly diagnosed asthma or COPDAniek F Markus, Peter R Rijnbeek, Jan A Kors, et al.
Journal of the American Medical Informatics Association : JAMIA|October 20, 2022
Integrating real-world data from Brazil and Pakistan into the OMOP common data model and standardized health analytics framework to characterize COVID-19 in the Global SouthElzo Pereira Pinto Junior, Priscilla Normando, Renzo Flores-Ortiz, et al.
Frontiers in Pharmacology|September 3, 2025
Trends in prescription opioid use in Europe: A DARWIN EU<sup>®</sup> multinational cohort study including seven European countriesJunqing Xie, Mike Du, Yuchen Guo, et al.
Pharmacoepidemiology and Drug Safety|May 22, 2024
Calculating daily dose in the Observational Medical Outcomes Partnership Common Data ModelTheresa Burkard, Kim López-Güell, Artem Gorbachev, et al.
Pharmacoepidemiology and Drug Safety|October 16, 2024
Time Series Methods to Assess the Impact of Regulatory Action: A Study of UK Primary Care and Hospital Data on the Use of FluoroquinolonesYuchen Guo, Berta Raventós, Martí Català, et al.
The Lancet. Rheumatology|January 17, 2024
Opioid use, postoperative complications, and implant survival after unicompartmental versus total knee replacement: a population-based network studyEdward Burn, James Weaver, Daniel Morales, et al.
European Journal of Epidemiology|April 3, 2026
CohortCharacteristics: an R package for population characterisation in observational studies using the OMOP common data modelMike Du, Albert Prats-Uribe, Núria Mercadé-Besora, et al.
Seminars in Arthritis and Rheumatism|June 21, 2022
Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: A multinational real-world cohort analysisCynthia Yang, Ross D Williams, Joel N Swerdel, et al.
Arthritis Care & Research|March 25, 2024
Incident Use of Hydroxychloroquine for the Treatment of Rheumatoid Arthritis and Systemic Lupus Erythematosus During the COVID-19 PandemicNúria Mercadé-Besora, Yuchen Guo, Mike Du, et al.
Pageof 8